“Empagliflozin-Induced Acute Pancreatitis and Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus” (2022) American Journal of Chemistry and Pharmacy, 1(2), pp. 1–4. doi:10.54536/ajcp.v1i2.747.